Your browser doesn't support javascript.
loading
Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic-pharmacodynamic profiles of rivaroxaban.
Zhang, Hanxu; Zhang, Zhuo; Liu, Zhiyan; Mu, Guangyan; Xie, Qiufen; Zhou, Shuang; Wang, Zhe; Cao, Yu; Tan, Yunlong; Wei, Xiaohua; Yuan, Dongdong; Xiang, Qian; Cui, Yimin.
Afiliação
  • Zhang H; Department of Pharmacy, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, 100034, China.
  • Zhang Z; School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China.
  • Liu Z; Department of Pharmacy, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, 100034, China.
  • Mu G; Department of Pharmacy, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, 100034, China.
  • Xie Q; Department of Pharmacy, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, 100034, China.
  • Zhou S; Department of Pharmacy, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, 100034, China.
  • Wang Z; Department of Pharmacy, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, 100034, China.
  • Cao Y; School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China.
  • Tan Y; Department of Pharmacy, Peking University First Hospital, No. 8, Xishiku Street, Xicheng District, Beijing, 100034, China.
  • Wei X; Office of Drug Clinical Trial Management, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Yuan D; Psychiatry Research Center, Beijing HuiLongGuan Hospital, Peking University, Beijing, China.
  • Xiang Q; Clinical Trial Research Center, Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Cui Y; Department of Pharmacy, The 7Th People's Hospital of Zhengzhou, Zhengzhou, Henan, China.
Hum Genomics ; 16(1): 72, 2022 12 28.
Article em En | MEDLINE | ID: mdl-36578040

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Rivaroxabana Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Rivaroxabana Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article